DACLAVIR is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults (see Recommended Dose under Dosage & Administration, Instruction for Use, Precautions and Pharmacology: Pharmacodynamics under Actions).
For hepatitis C virus (HCV) genotype specific activity, (see Precautions and Pharmacology: Pharmacodynamics under Actions).